A detailed history of Unison Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Unison Advisors LLC holds 5,078 shares of BIIB stock, worth $742,555. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,078
Previous 5,078 -0.0%
Holding current value
$742,555
Previous $1.18 Million 16.4%
% of portfolio
0.12%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 20, 2021

SELL
$282.99 - $369.05 $382,036 - $498,217
-1,350 Reduced 21.0%
5,078 $1.44 Million
Q2 2021

Jul 28, 2021

BUY
$259.0 - $414.71 $136,493 - $218,552
527 Added 8.93%
6,428 $2.23 Million
Q2 2020

Jul 09, 2020

BUY
$258.66 - $342.55 $45,782 - $60,631
177 Added 3.09%
5,901 $1.58 Million
Q1 2020

Apr 29, 2020

BUY
$268.85 - $341.04 $1.54 Million - $1.95 Million
5,724 New
5,724 $1.81 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Unison Advisors LLC Portfolio

Follow Unison Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unison Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unison Advisors LLC with notifications on news.